What is Cyanocobalamin Market?
Cyanocobalamin is a man-made form of vitamin B12 used to prevent and treat low blood levels of vitamin B12. It is important for cell reproduction, growth, blood formation and protein and tissue synthesis. Cyanocobalamin is used to treat vitamin B12 deficiency in people with pernicious anemia and other conditions. The deficiency of Vitamin B12 may result in a low number of red blood cells (anemia), stomach/intestine problems, and permanent nerve damage.
The market study is being classified by Type (Cyanocobalamin Injection, Cyanocobalamin Oral and Cyanocobalamin Spray) and major geographies with country level break-up.
Luitpold Pharmaceuticals, Inc. (United States), Endo International plc (Ireland), Bristol Myers Squibb (United States), Sanofi S.A. (France), Teva Pharmaceutical Industries Ltd. (Israel), Merck & Co., Inc. (United States), Mylan N.V. (United States), Bayer AG (Germany), Pfizer (United States) and Angelini (Italy) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Biological E. (India) and Shandong Huaxin Pharmaceutical Group Co. Ltd. (China).
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Cyanocobalamin market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Cyanocobalamin market by Type, Application and Region.
On the basis of geography, the market of Cyanocobalamin has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing Number of People with Vitamin B12 Deficiency
- Increased Number of Hospitals and Diagnostic Centres
- Growing Demand for Cyanocobalamin from Food Industry in Food Supplements
- Side Effects of the Cyanocobalamin
- Growth in the Healthcare Industry
- Increasing Number of Online Customers
- Stringent Government Rules and Regulations
In November 2019, -Bristol-Myers Squibb Company has announced that it has completed its acquisition of Celgene Corporation following the receipt of regulatory approval from all government authorities required by the merger agreement and, as announced on April 12, 2019, approval by Bristol-Myers Squibb and Celgene stockholders.
Key Target AudienceCyanocobalamin Manufacturers, Distributors, Emerging Companies, Research Professionals and End-users
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase